Aquestive Therapeutics Completes Enrollment in Libervant (diazepam buccal film) Crossover Study
WARREN, N.J., June 4, 2019 /PRNewswire/— Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, today announced it has completed enrollment in a single dose crossover pharmacokinetic (PK) trial for Libervant™... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 4, 2019 Category: Pharmaceuticals Source Type: clinical trials

Therapeutic Drug Monitoring of Anxiolytics in Children
Condition:   Anxiolytics Intervention:   Drug: Midazolam/diazepam/propofol Sponsor:   Wei Zhao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2019 Category: Research Source Type: clinical trials